GlassScriptPhysician profile
Hartmuth Bittner
NPI 1104182245
$3,458.95
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,563 · 2020: $1,294 · 2021: $91.59 · 2023: $403 · 2024: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $389 · Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $389.00 |
| Food and Beverage | $121.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,660.94 | 2019-2020 | |
| Baxter Healthcare | $389.00 | 2023 | Fluid Sys - Plasma-Lyte |
| Abbott Laboratories | $196.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $91.59 | 2021 | |
| Edwards Lifesciences Corporation | $86.46 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Mindray Ds USA, INC. | $20.57 | 2024 | A7 Anesthesia System |
| Novo Nordisk INC | $14.08 | 2023 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hartmuth Bittner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.